Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Large B-Cell, Diffuse 11Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 1

Interventions

Rituximab 117Cyclophosphamide 104fludarabine phosphate 52Peripheral Blood Stem Cell Transplantation 52Cytarabine 47Etoposide 44Mycophenolic Acid 41Filgrastim 40Whole-Body Irradiation 37Tacrolimus 36Melphalan 35Bortezomib 34Methotrexate 33Cyclosporine 33Busulfan 31Radiotherapy 30Vincristine 28Doxorubicin 27Dexamethasone 27Carmustine 25Antilymphocyte Serum 25Lenalidomide 23Bendamustine Hydrochloride 23ibrutinib 22Granulocyte Colony-Stimulating Factor 20obinutuzumab 18fludarabine 18acalabrutinib 18Prednisone 18venetoclax 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Mantle-Cell × R-CHOP protocol × Clear all
NCT04566887 2025-02-18

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

University Health Network, Toronto

Phase 2 Recruiting
105 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT02633137 2024-08-30

Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
49 enrolled 8 charts
Lymphoid

Lymphoma, Mantle-Cell

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡